Last reviewed · How we verify
HER.CAR CMV-specific CTLs — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
HER.CAR CMV-specific CTLs (HER.CAR CMV-specific CTLs) — Baylor College of Medicine.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HER.CAR CMV-specific CTLs TARGET | HER.CAR CMV-specific CTLs | Baylor College of Medicine | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HER.CAR CMV-specific CTLs CI watch — RSS
- HER.CAR CMV-specific CTLs CI watch — Atom
- HER.CAR CMV-specific CTLs CI watch — JSON
- HER.CAR CMV-specific CTLs alone — RSS
Cite this brief
Drug Landscape (2026). HER.CAR CMV-specific CTLs — Competitive Intelligence Brief. https://druglandscape.com/ci/her-car-cmv-specific-ctls. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing